Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation.
about
Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunctionMolecular weight dependence of the depletion attraction and its effects on the competitive adsorption of lung surfactant.Rediscovering the Schulze-Hardy rule in competitive adsorption to an air-water interfaceOvercoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.Enhanced surfactant adsorption via polymer depletion forces: a simple model for reversing surfactant inhibition in acute respiratory distress syndromeVisualizing the analogy between competitive adsorption and colloid stability to restore lung surfactant functionA freeze-fracture transmission electron microscopy and small angle x-ray diffraction study of the effects of albumin, serum, and polymers on clinical lung surfactant microstructure.Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.On the low surface tension of lung surfactant.Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: albumin-inhibited pulmonary surfactant films and the effect of SP-AMechanisms of polyelectrolyte enhanced surfactant adsorption at the air-water interface.X-ray diffraction and reflectivity validation of the depletion attraction in the competitive adsorption of lung surfactant and albuminCompetitive adsorption: a physical model for lung surfactant inactivation.Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.Kinematic viscosity of therapeutic pulmonary surfactants with added polymers.A Proposed In Vitro Method to Assess Effects of Inhaled Particles on Lung Surfactant Function.
P2860
Q28308215-6EEB0241-2DFD-4E52-AAA6-034F8C3022ACQ30484363-33915395-9309-426C-AD25-86173551906FQ30489870-81D2E9FC-79F9-4E01-BFBC-326114506A20Q33712598-69E9F9AA-A1E9-4D4F-9B39-006ADA035EA7Q35220151-6C68AA25-3743-40F3-8FA4-0A31E6DF78C6Q35769953-A162CCFB-FCBA-485F-BA7D-BA323E73BF03Q35881257-04417B28-5435-4FE3-B2D1-DD1AD8B651BCQ35917662-F3B55A11-DBBB-4654-B86D-C8B19C59A96FQ36849340-C4ADBC7D-8E22-4E10-BD4C-764B612EC995Q36856485-09F75CDF-ED78-4220-B6EB-BEC94EC77EB1Q37181616-11C90127-6133-485F-A1A8-A4D088A94F57Q37281884-D663B1BE-A2F9-41C0-B6AF-9493C4485CDAQ37320766-A39B161B-7837-463B-B0B1-0460668DAB66Q41843692-8A583677-1F32-458C-B1C2-FDBFCA501ABFQ43143138-BE2D1C98-FC48-4A6B-9722-44635C744330Q48110875-6AE97502-65C2-437E-BD8C-29DD502C7959
P2860
Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Chitosan enhances the in vitro ...... albumin-induced inactivation.
@en
Chitosan enhances the in vitro ...... albumin-induced inactivation.
@nl
type
label
Chitosan enhances the in vitro ...... albumin-induced inactivation.
@en
Chitosan enhances the in vitro ...... albumin-induced inactivation.
@nl
prefLabel
Chitosan enhances the in vitro ...... albumin-induced inactivation.
@en
Chitosan enhances the in vitro ...... albumin-induced inactivation.
@nl
P2093
P2860
P1433
P1476
Chitosan enhances the in vitro ...... albumin-induced inactivation.
@en
P2093
A Wilhelm Neumann
Arash Shafiei
Hamdi Alolabi
Michael L Hair
Ningxi Kang
Peter N Cox
Zdenka Policova
P2860
P304
P356
10.1203/01.PDR.0000227558.14024.57
P407
P577
2006-08-01T00:00:00Z
P5875
P6179
1007159713